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oppler-Guided Regulation of a Telemetrically
perated Adjustable Pulmonary Banding System
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OBJECTIVES We report on the Doppler-assessed regulation of an adjustable pulmonary artery band (PAB)
in an animal model and in our first group of patients.
BACKGROUND Indications for pulmonary artery banding have expanded to include patients requiring a late
arterial switch. A telemetry-operated, fully implantable, adjustable PAB system (FloWatch-
PAB, Endoart SA, Lausanne, Switzerland) has been developed to facilitate these operations.
METHODS The device was implanted in 13 minipigs (age one to five months, weights 3.2 to 12.0 kg).
The main study was performed on nine minipigs with adjustments of the PAB at
implantation and at 1, 3, 5, 8, and 12 weeks after, assessed by Doppler pressure gradients.
Explanation was performed 12 weeks after surgery. A long-term histology study (6 months
and 14 months after surgery) was done on the other four minipigs. After approval by the
ethics committee, the device was implanted in eight patients with weights between 2.8 and
9 kg to decrease pulmonary blood flow and pressure and to retrain the left ventricle before
arterial switch. The device was progressively tightened, with increasing transband Doppler
gradients. Follow-up was one to three months.
RESULTS An excellent correlation between transbanding systolic pressure gradient and degree of PAB
constriction was encountered in the minipig study as well as in the human setting. No early
or late deaths or reoperations occurred. Malfunction of the device was noted in three of 21
implanted devices. Two were related to surgically inflicted damage at implantation and one
to an electronic problem that was fixed by resetting the control device.
CONCLUSIONS The device offers a Doppler-controllable adjustment of pulmonary blood flow. It permits
controlled tightening and release of the band, which improves perioperative and postoperative
courses and decreases surgical interventions to adjust tightness of the band. It allows a
protracted occlusion protocol, which may provide the best effect on retraining the left
ventricle. (J Am Coll Cardiol 2004;44:1087–94) © 2004 by the American College of
Cardiology Foundationc
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she indications for pulmonary artery banding (PAB) tradi-
ionally include patients with multiple ventricular septal
efects (VSDs) and patients with complex heart disease and
ncreased pulmonary blood flow in which the pulmonary
ascular bed needs to be protected while awaiting later
urgical repair (1). The indications for PAB have recently
xpanded, including patients requiring a late switch opera-
ion because of late referral or previous atrial palliation (2).
Traditionally, the band is placed around the pulmonary
rtery (PA) during an operation and tightened progressively
o achieve a distal PA pressure that is ideally one-half to
ne-third of the systemic pressure (3). The intraoperative
onditions, however, not infrequently prevent an optimal
ightening of the band. The reasons for this are the different
emodynamics under general anesthesia, the perioperative
nstability of the patients, and the inability of the ventricle
o deal immediately with the increased workload. This
From the *Division of Pediatric Cardiology and the †Department of Cardiovas-
ular Surgery of the University Hospital of Canton Vaud (CHUV), Lausanne,
witzerland; and the ‡Laboratory of Hemodynamics and Cardiovascular Technology,
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Manuscript received September 11, 2003; revised manuscript received March 1,(004; accepted May 4, 2004.ombination of factors may induce an important risk of
omplications during the perioperative and postoperative
ourse, which could even lead to surgical interventions to
ither tighten or open the band sufficiently (4–6).
A telemetry-operated, completely implantable, adjustable
AB was used to facilitate these operations (7). This study
eports on the initial experience with the FloWatch im-
lanted in minipigs and compares it to that of our first
roup of patients.
ETHODS
aterial used. A new adjustable PAB implant (FloWatch-
AB, EndoArt SA, Lausanne, Switzerland) was used in this
tudy. The banding is adjusted using a passive telemetry
ystem operating at 27 MHz requiring the use of an external
ontrol unit (Figs. 1 and 2).
nimal investigation. Animal study was performed after
pproval by the Animal Ethics Committee of the “Société
étérinaire du Canton de Vaud” (No. 14131, 24.04.01).
he FloWatch was implanted in 13 minipigs age one to five
onths, divided into two groups, one for the main Doppler
tudy (nine minipigs) and the other for the histology study
four minipigs). The weight of the minipigs in group 1 was
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Adjustable Pulmonary Artery Banding September 1, 2004:1087–94.1  1.5 kg at implantation (range 3.4 to 6.9 kg) and 12.7
3.7 kg at explantation (range 19.4 kg). For group 2 the
eight was 12  0.4 kg at implantation. The implantation
round the main PA was performed through a left thora-
otomy with the pigs under general anesthesia.
NIMAL DOPPLER STUDY. The main study was performed
n nine minipigs (group 1). The device was implanted and
djustments were performed with Doppler gradient mea-
urements at implantation and at 1, 3, 5, 8, and 12 weeks
fter implantation. Each time the FloWatch was completely
pened, then tightened stepwise in 10% increments until
he gradient started to decrease, which was interpreted as a
ign of impending right heart failure. The device was then
ompletely reopened and tightened again to the desired
osition. At each step the transbanding pressure gradients
ere measured by Doppler. The FloWatch was explanted at
2 weeks by median sternotomy with the subjects under
eneral anesthesia, and the pigs were destroyed. The ex-
lanted device underwent testing to ensure its functionality,
nd histology was performed on the PA and the surround-
ng capsule.
The measurements at implantation were performed with
he pigs under general anesthesia with isoflurane. For all the
ther adjustments the piglets were sedated with Ketaminol
0% (25 mg/kg im). The animals were placed under a
eating lamp to maintain body temperature and kept on
oom air. Continuous wave Doppler echocardiography was
erformed with the pigs in the supine position from the
arasternal short axis view using a commercially available
chocardiography system and a 3.5 MHz mechanical trans-
ucer. The cursor was placed across the center of the device
o obtain the maximum and mean velocities. Each measure-
ent was repeated three times and averaged (8).
ONG-TERM HISTOLOGY STUDY. This was performed in
hree minipigs six months after implantation (group 2) and
n one minipig 14 months after implantation. After explan-
ation the PA was observed macroscopically, then sliced,
tained, and assessed in a microscopically qualitative and
emi-quantitative manner to characterize local tolerance
arameters.
uman investigation. After approval by the Research
thics Committee of the Medical Faculty of the University
f Lausanne (No. 44/02, 08.04.02) for implantation in
umans, the FloWatch was implanted in eight patients.
he characteristics of the patients are listed in Table 1.
dditional procedures performed at the same time as
loWatch implantation included patent ductus arteriosus
igation in Patients 1, 3, and 4 and division of the anterior
Abbreviations and Acronyms
PA  pulmonary artery
PAB  pulmonary artery band/banding
VSD  ventricular septal defectrch in Patient 2. The device was implanted by left lateral pigure 1. (A) General view of the FloWatch implant. The piston has a stroke
f 3 mm for tightening or loosening of the banding. The silicone membrane
s flexible and extensible, protecting the piston and the inside of the case from
ody fluids while allowing the piston to perform its adjustment movements.
he measurements of the FloWatch when clipped are 26  18.4  17 mm
length  width  height). (B) View of the implant in its two extreme
ositions: the adjustable surface where the pulmonary artery is confined varies
ith the displacement of the piston. The 3-mm piston stroke causes a variation
f the adjustable surface between 72 mm2 and 38 mm2 with great precision.
C) View of the external control unit and its external antenna, which should be
laced on the patient’s thorax just above the implant.
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September 1, 2004:1087–94 Adjustable Pulmonary Artery Bandinghoracotomy in Patients 1 and 2 and by median sternotomy
n the others. The FloWatch was tightened stepwise over a
eriod of several weeks with increasing transband Doppler
radients. The measurements were performed with contin-
ous wave Doppler in the parasternal short axis view using
7.5-MHz or 5-MHz phased-array transducer with the
ursor aligned parallel to the PA in the center of the device
o get the maximum velocity. The Doppler measurements
ere made by the same cardiologist for all the patients.
hree measurements were obtained at each adjustment and
veraged. Follow-up was from one to three months. Ad-
ustments were performed on average six times per patient
range 1 to 12) with 65% of the adjustments performed in
he first week, 20% in the second week, and 15% within
hree months after implantation. Ninety-two percent of the
djustments were made to tighten the band; in 8% to release
t. No early or late mortality occurred and no reoperations
ere required because of the device, but device dysfunction
ccurred in two patients.
tatistical analysis. All data were expressed as mean 
D. Comparisons were made with student t test. Differ-
nces were considered to be significant for p  0.05.
ESULTS
nimal investigation. ANIMAL DOPPLER STUDY. One of
he nine piglets included in the Doppler study died suddenly
f unknown cause three weeks after implantation. The last
easurements had been performed one week before death
nd had shown a maximum gradient of 31 mmHg. The
evice was tightened at 35% at time of death. Autopsy
howed no etiology and the device was functioning nor-
ally. One other device did not react to the programmed
egulations at any time after implantation. A perforation of
he membrane covering the piston of the device, occurring
ost likely at implantation, was found at explantation. An
mportant corrosion of all the electromechanical parts inside
igure 2. FloWatch adjustable surface in function of the FloWatch
egulation range. The adjustable surface was measured using as a basis
umerical pictures of the FloWatch at different positions. Error bars
ndicate SD (n  6).he device, which was caused by contact with body fluid, Fxplains this absence of reaction. These two minipigs were
herefore not included in this study.
Figure 3 shows recordings of the systolic transbanding
ressure gradient measured on a given pig. This figure
llustrates that over time the pressure gradient increases and
hat the rate of this increase could be modulated by the
hosen degree of FloWatch regulation: between weeks 3
nd 5, the cardiovascular adaptation was greater than
etween weeks 1 and 3 because of the important degree of
ightening during this period (35%, as opposed to 20%
etween weeks 1 and 3). However, if we compare the
volution of all seven minipigs (Fig. 4), a remarkable
ifference exists between the regulation range of the Flo-
atch and the resulting Doppler pressure gradients at
mplantation (week 0) and after 1, 3, 5, 8, and 12 weeks. In
eek 0 only a limited response to tightening is registered,
hereas at 5, 8, and 12 weeks, the achieved gradient with
he same regulation range of the device is significantly
ncreased. An excellent correlation between the systolic
ressure gradient and the percentage stroke of the device
ould be established.
Another way to measure the efficacy of the device is to
lot the evolution of the gradient regulation range (Fig. 5).
his graph shows that the regulation range (range between
hite squares and white dots) increases significantly with
ime. In all seven minipigs, the PA re-expanded completely
fter removal of the FloWatch. This suggests that a surgical
econstruction of the PA may be avoided. The explanted
evices were all functioning and the PA and device-
urrounding capsule were analyzed. The results were iden-
ical to those in the animal histology study.
NIMAL HISTOLOGY STUDY. The weight of the three
inipigs in the six months group (group 2) at explantation
as 25.1  3.2 kg (mean  SD) and 40.5 kg for the one
inipig evaluated after 14 months. At explantation it was
hown that the adjustability of the FloWatch was still
ffective in all four minipigs (strong response of the trans-
anding gradient) and thus that the fibrotic tissues do not
lter the possibility to activate and adjust the device. Each
able 1. Characteristics of the Eight Patients
Patient
Number Diagnosis
Age at
Implantation
[weeks]
Weight at
Implantation
[kg]
1 CAVSD 4.5 3.5
2 Multiple VSDs/double
aortic arch
21.5 6.44
3 Multiple VSDs 10 4.2
4 Univentricular heart 10.2 3.7
5 d-TGA 4.6 3.24
6 VSD/arch hypoplasia 4.6 2.82
7 DORV/straddling TV 165 9
8 d-TGA/VSD 46 6
Median 10 3.95
AVSD  complete atrioventricular septal defect; DORV  double-outlet right
entricle; d-TGA  d-transposition of the great arteries; TV  tricuspid valve;
SD  ventricular septal defect.loWatch was found to be encapsulated in a fibrotic
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Adjustable Pulmonary Artery Banding September 1, 2004:1087–94apsule. No device was found to have migrated or rotated
round the artery. In addition, the fibrotic capsule was as
hin and smooth as those found around pacemakers (Fig. 6).
n the minipig at 14 months, the device was removed as
ould be done during a standard surgical repair. This
emoval was very easy and caused no damage to the PA. The
igure 3. Example of systolic transbanding pressure gradient as a function o
) the FloWatch was adjusted to get the curve. Afterward, the degree of ad
atural growth and cardiovascular adaptation lead to the second curve ( a
egree of regulation was again set to 20% ( working point). Two weeks la
f adjustment was increased to 35% ( starting working point, in white). T
o the curve at week 5 (solid line). At week 5, the degree of regulation wa
ollowing 7 weeks.
igure 4. Systolic transbanding pressure gradient in function of FloWatch
egulation range for the minipig Doppler study. Only points with at least
ve measurements for the same adjustment range are represented in the
raph. Error bars indicate SD (5  n  7). Solid lines are a mathematical
t based on a hemodynamic model of stenosis. bA re-expanded completely after removal of the device and
he explanted devices were all functioning normally. The
acroscopic analysis of the PA and of the device-
urrounding capsule showed no major abnormal signs. The
acemaker-like capsule was 2- to 4-mm thick. The PA
Watch regulation range as obtained in one minipig. At implantation (week
ent was set to 20% ( starting working point, in white). After one week,
working point, in black). After full-range regulation to get the curve, the
slower cardiovascular adaptation leads to the third curve. Then the degree
gmented load induces an important cardiovascular adaptation, which leads
inished to 20%, which induces no more cardiovascular adaptation for the
igure 5. Evolution of the systolic transbanding pressure gradient range of
he minipig Doppler study. White squares situation with the FloWatch
ully open (degree of regulation set to 0%, corresponding to the left end of
ach curve in the example on Fig. 3); white circles  maximum values
olerated by the minipig (corresponding to the right end of each curve in
he example on Fig. 3); black diamonds  working points (corresponding
o the gray working points of each curve in the example on Fig. 3). Errorf Flo
justm
rrival
ter, a
his au
s dimars indicate SD (6  n  7).
s
f
t
s
f
l
t
l
w
r
n
H
t
fi
g
p
s
w
q
s
f
g
d
t
s
t
t
p
v
w
1
u
t
r
c
l
F
s
1091JACC Vol. 44, No. 5, 2004 Sekarski et al.
September 1, 2004:1087–94 Adjustable Pulmonary Artery Bandinghowed no thrombus, but generally exhibited a limited
olding and thickness narrowing in the area compressed by
he FloWatch. The microscopic analysis showed a device-
urrounding capsule infiltrated with some macrophages and
ew lymphocytes or giant cells. Lymphocytes were usually
ocated at the material interface. The microscopic analysis of
he PA showed some alterations of the media including
imited degenerative signs. In two cases the reduction of PA
all thickness was 50%. The neointima was always inter-
upted: in several segments of the PA endothelial cells were
ot visible.
uman investigation. There are clearly two different pat-
erns of results, depending on the indication for PAB. The
rst is to retrain the left ventricle in transposition of the
reat arteries when the left ventricle has involuted. As is
ictured in Figure 7, these curves most closely match the pig
tudy. This figure shows the slowly increasing gradients
ith increasing percentage stroke over time and the conse-
igure 6. (A) Explantation of the FloWatch in one minipig after 14 mo
urrounding the FloWatch. (B) Pulmonary artery (PA) of the minipig aftuently increasing left ventricular wall thickening, with eimultaneous stabilization of the gradient occurring around
our weeks after implantation.
The second pattern is summarized in Figure 8, which
roups all patients in whom the FloWatch was placed to
ecrease pulmonary blood flow and pulmonary pressures. In
hese patients the subpulmonary ventricle had already been
ubjected to a significant volume overload and the possibility
o use the right-to-left shunt as an escape mechanism. In
hese patients the adaptation was much quicker with the
ossibility to tighten the device more rapidly without risking
entricular failure. In two cases malfunction of the device
as noted. In Patient #3 (at 55% occlusion and a gradient of
35 mm Hg), reopening had to be done with the patient
nder general anesthesia (to ensure a better coupling). After
his complete reopening, a 70 mm Hg residual gradient
emained which allowed the patient to continue his growth
ourse. Surgical correction was performed three months
ater, at which time the device was explanted. Post-
the core of the FloWatch and the thin pacemaker-like fibrotic capsule
months: inside view at the location of the FloWatch.nths:
er 14xplantation evaluation of the device showed a perforated
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Adjustable Pulmonary Artery Banding September 1, 2004:1087–94embrane, which probably occurred at implantation and
aused the problem. In Patient #6 the occlusion of the
evice was gradually increased to 55% with a gradient of 70
m Hg, at which point it was noticed that the device could
e tightened but released only with difficulty. This was due
o a communication problem between the device and the
ontrol unit and could be modified by resetting the param-
ters of the microchip card of the control unit without
aving to explant the device.
ISCUSSION
ulmonary artery banding is a palliative operation and is
sed in a variety of heart lesions (1,9–12). Two categories of
atients benefit from this operation: those with an excess of
ulmonary blood flow and a subsequent increased PA
igure 7. Evolution of the systolic transbanding pressure gradient (A) of
he FloWatch regulation range (B), and of the left ventricle posterior wall
hickness (C) for Patient #5 (d-transposition of the great arteries).ressure, who cannot undergo a complete repair in infancy auniventricular hearts, multiple VSDs of the Swiss Cheese
ype) and those with left ventricles requiring retraining to be
ble to sustain high pressures (late arterial switches) (2,13–
5). The difficulty with the traditional band lies in achieving
tight enough band during surgery (6,16,17). This issue is
omplicated by the altered hemodynamics during anesthe-
ia, the intraoperative instability or cyanosis of the patients,
nd the inability of the ventricle to cope with the suddenly
ncreased workload. A number of these patients will there-
ore require a second operation either to tighten or loosen
he band.
In the wake of the trend to perform late switches on
atients with either a previous atrial palliation or in patients
resenting late for an initial arterial switch, preparative PAB
as been advised to retrain the left ventricle (2,13–15).
arious techniques to do this have been described (18–26).
ee (2) described a partly exteriorized banding, which
igure 8. Evolution of the systolic transbanding pressure gradient (A) and
f the FloWatch regulation range (B) for all the patients together with
xception of Patient #5 (d-transposition of the great arteries). Time is given
n logarithmic scale, day 1 being the day of surgery; logarithmic scale. Error
ars indicate SD (n  7, 7, 6, 6, 7, 7, 6, 4, from left to right, respectively).llowed gradual tightening in the intensive care during the
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September 1, 2004:1087–94 Adjustable Pulmonary Artery Bandingrst days after the operation. This gradual tightening of the
and allowed an optimal preparation of the left ventricle for
ts new role after the subsequent switch operation. This
bservation parallels the results in the animal study, where a
apid closure of the banding resulted in a lower gradient
aused by relative pump failure of the untrained ventricle,
hereas gradual tightening over weeks resulted in a better
entricular performance and thus a larger gradient. The
tudy in minipigs demonstrates very well the relationship
etween the adjustments of the band, the Doppler gradi-
nts, and the gradual tightening of the FloWatch. The
ransposition patient seems to parallel this observation. A
econd advantage of the gradual narrowing of the band
ight be located in the type of hypertrophic response of the
entricle. Bauer et al. suggest that a gradual, protracted, and
tepwise increase of ventricular pressure loading will in
ontrary to an acute one, allow the maintenance of the
ascade of messenger ribonucleic acid for a longer time,
hich would allow more useful trophic alterations, such as
eoangiogenesis and myosin increase, to occur (27). The left
entricular retraining, as suggested by Mee (2) for ventricles
ithout off-load capabilities such as VSDs finds an optimal
nd sterile substitute in the telemetrically operated banding
evice described in this study.
Banding of the pulmonary artery in the presence of a
SD or in single-ventricle anatomy, as off-load capability
or the right ventricle, occurs in a totally different hemody-
amic situation, which allows the tightening of the banding
o be performed faster. The major advantage of the Flo-
atch here is in its reopening capability. As was shown in
he animal study and in several patients, the device can be
eopened gradually in adaptation to the natural growth.
his allows a tight banding early on to prevent congestive
eart failure and a gradual reopening accompanying growth,
ending the ideal moment for surgical correction. The
losure and reopening capacity of the FloWatch, as shown
n Figure 5, proves to function well and to cover the range
equired for patients in need of PAB. Moreover, the
acemaker-like fibrous capsule surrounding the FloWatch
ever prevented the device from being adjusted, even after a
4-month follow-up. Finally, no dangerous injury to the PA
r surrounding structure has been observed in any animal
xperiment. Thus, the long-term safety and reopening
apability of the device should allow for reopening the
anding gradually in adaptation to the natural growth, as
as already been shown in some patients.
This differentiated use of the device will eventually result
n various implanting and adjustment protocols for the
elected indications. The indications for the use of the
loWatch might also be extended once the experience
rows. One of these indications might include patients with
ortic arch hypoplasia and VSD to allow spontaneous
rowth of the arch while congestive heart failure is being
revented and the pulmonary vascular bed is protected (28).
Limitations of this study include the relatively smallumber of minipigs included in the animal investigation,hich allowed only the implementation of one protocol and
revented extensive comparison of various time schedules
sed in the tightening of the PA. In addition, only a limited
umber of invasive flow and pressure measurements were
erformed in order to improve survival of the experimental
nimals. This leaves Doppler studies as the predominant
gold standard.” The human study group is small and
onsists of a varied group of diagnoses and indications,
reventing meaningful statistical analysis; however, the
nitial results of the European trial are encouraging (29).
inally, it is important to realize that device failure has been
problem which should be solved; the membrane especially
eems to be prone to puncturing, and surgeons should pay
pecific attention to this at implantation.
ONCLUSIONS
he described technology of progressive, noninvasively
ontrollable adjustment of pulmonary blood flow in the
nimal model and in a variety of forms of congenital heart
isease permits not only accurate tightening, but also release
f the pulmonary banding if required. This will allow
mprovement of the perioperative and post-operative course
f these patients and may prevent multiple surgical inter-
entions to adjust the tightness of the PAB. The animal
tudy suggests that in patients without a ventricular decom-
ression option (i.e., a VSD), a protracted occlusion proto-
ol may be the safest and provide the best effect on
etraining of the ventricle.
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irector of the Division of Pediatric Cardiology, University
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